- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/22 - Antivirals for DNA viruses for herpes viruses
Patent holdings for IPC class A61P 31/22
Total number of patents in this class: 1257
10-year publication summary
|
34
|
41
|
39
|
89
|
109
|
139
|
131
|
129
|
140
|
47
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Modernatx, Inc. | 1181 |
27 |
| Glaxosmithkline Biologicals S.A. | 1701 |
19 |
| The Council of the Queensland Institute of Medical Research | 155 |
15 |
| Novartis AG | 11238 |
12 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 588 |
12 |
| KM Biologics Co., Ltd | 86 |
12 |
| Aic246 AG & Co. KG | 38 |
12 |
| Albert Einstein College of Medicine, Inc. | 528 |
11 |
| Jiangsu Hengrui Medicine Co., Ltd. | 780 |
11 |
| Xiamen University | 488 |
11 |
| Merck Sharp & Dohme LLC | 3689 |
10 |
| The Regents of the University of California | 18943 |
9 |
| The Trustees of the University of Pennsylvania | 4122 |
9 |
| Takeda Pharmaceutical Company Limited | 2961 |
9 |
| The Johns Hopkins University | 5377 |
8 |
| Aicuris GmbH & Co. KG | 120 |
8 |
| Gilead Sciences, Inc. | 1879 |
8 |
| Boehringer Ingelheim International GmbH | 4629 |
7 |
| Astellas Pharma Inc. | 1145 |
7 |
| City of Hope | 943 |
7 |
| Other owners | 1033 |